Last reviewed · How we verify
NCT04024046
Uqora Supplements in Women With UTIs
trial testing Uqora in Urinary Tract Infections in 360 participants. Terminated before completion.
16 September 2020
Quick facts
| Lead sponsor | Hawthorne Effect Inc. |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 360 |
| Start date | 18 April 2019 |
| Primary completion | 16 September 2020 |
| Estimated completion | 16 September 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Uqora
- Group1
- Group 2
Conditions studied
- Urinary Tract Infections — all drugs for Urinary Tract Infections →
Sponsor
Hawthorne Effect Inc.
Who can join
18 and older, female only, with Urinary Tract Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a virtual study which will invite females over the age of 18 who have had 2 or more UTIs in the past 6 months to participate. The investigators are looking at the impact of a daily dietary supplement with the recurrence of UTIs. Participants will be blinded and randomized randomized into the Control Group or Groups 1 or 2. Control Group will receive a Placebo Drink-Mix and Placebo Capsules. Group 1 will receive the Uqora Drink-Mix and Placebo Capsules. Group 2 will receive the Uqora Drink-Mix and Uqora Capsules. Each group will receive 180 day supply of the products.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04024046
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urinary Tract Infections
Currently open trials in the same condition.
- NCT06976125 — Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulat · NA · recruiting
- NCT06808451 — Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture · NA · recruiting
- NCT07186465 — Microbiome-Modulating Prophylaxis RCT: Antibiotic vs Gynoflor in Postmenopausal Women With Recurrent Cystitis · Phase 4 · recruiting
- NCT07207291 — Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers · Phase 1 · recruiting
- NCT06715306 — Intravenous Versus Oral Treatment of the Main Acute Infections · NA · recruiting
Other Hawthorne Effect Inc. trials
Trials by the same sponsor.
- NCT04153552 — Upset Stomach Relief for Mild and Moderate Indigestion and Heartburn · NA · completed
- NCT04103099 — Impact of HLNatural Immune Supplement on Colds · NA · completed
- NCT04091555 — Evaluation of the Impact of the HL Natural, Inc. Tension Relief Product · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04024046 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hawthorne Effect Inc.
- Last refreshed: 27 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04024046.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing